According to Cognitive Market Research, the global Olopatadine Ophthalmic Market size is USD 1636.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 11.00% from 2024 to 2031.
North America held the major market of more than 40% of the global revenue with a market size of USD 654.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 490.86 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 376.33 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.0% from 2024 to 2031.
Latin America market of more than 5% of the global revenue with a market size of USD 81.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2031.
Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 32.72 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2031.
The Ophthalmic solution 0.2% held the highest olopatadine ophthalmic market revenue share in 2024
